COMP <GO>
AHCO vs SRTA // DIVIDEND YIELD & FCF PAYOUT SAFETY
AdaptHealth Corp. (NASDAQ) VS. Strata Critical Medical Inc. (Class A) (NASDAQ) • 15-METRIC TALLY: AHCO 4
— SRTA 4
■ METRIC PARITY
LAST: $5.93 (-1.66%) • MKT CAP: $808.5M
dividend-safety
0.00%
LAST: $4.75 (-0.21%) • MKT CAP: $420.2M
dividend-safety
0.00%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (AHCO VS. SRTA)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | AHCO | SRTA | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 18.80% | 20.90% | -2.10 | SRTA | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 2.20% | -7.10% | +9.30 | AHCO | /roic <GO> |
| EV/EBITDA & P/E Valuation | 6.1x | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | -13.92% | — | TIE | /fcf-yield <GO> |
| Operating Margin | 2.80% | -11.30% | +14.10 | AHCO | /operating-margins <GO> |
| Net Profit Margin | -2.20% | 21.00% | -23.20 | SRTA | /net-margins <GO> |
| Revenue Growth (YoY) | -0.50% | 34.30% | -34.80 | SRTA | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety ACTIVE | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.79 | 5.58 | -4.79 | SRTA | /balance-sheet <GO> |
| Piotroski F-Score Quality | 4/9 | 4/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 44.2 | 36.4 | +7.82 | AHCO | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 8.6x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $808.5M | $420.2M | $388.3M | AHCO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | AHCO REV | SRTA REV | AHCO GROSS % | SRTA GROSS % | AHCO FCF | SRTA FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $3.24B | $197.1M | 18.8% | 20.9% | $219.4M | -$58.5M |
| FY 2024 | $3.26B | $146.8M | 20.9% | 20.2% | $235.8M | -$33.4M |
| FY 2023 | $3.20B | $225.2M | — | — | $480.7M | -$32.3M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
AHCO // BETA —
SRTA // BETA —